Hologic, Inc., founded in 1982 and headquartered in Marlborough, Massachusetts, is a global medical technology company focused on advancing women's health through innovative products. The company offers a diverse range of diagnostic, surgical, and medical imaging solutions, including breast health and gynecological products, which are designed to improve patient outcomes and enable early detection of diseases.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| HOLX 3.25% 2029-02-15 USDHologic, Inc. | United States | 2029-02-15 | 3.250 | 3.47 |
| HOLX 3.25% 2029-02-15 USDHologic, Inc. | United States | 2029-02-15 | 3.250 | 3.47 |
| HOLX 4.63% 2028-02-01 USDHologic, Inc. | United States | 2028-02-01 | 4.625 | 4.66 |
| HOLX 4.63% 2028-02-01 USDHologic, Inc. | United States | 2028-02-01 | 4.625 | 4.66 |
| HOLX 4.63% 2028-02-01 USDHologic, Inc. | United States | 2028-02-01 | 4.625 | 4.66 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Hologic began issuing bonds in 2005, with a significant $500 million offering that marked its entry into the debt market. The company’s debt portfolio has since included notable issuances such as the $1 billion bond in 2020, which was used to finance acquisitions and expand its product offerings. Currently, Hologic's bonds yield around 3.5%, competitive within the healthcare sector, and feature provisions allowing for early redemption, reflecting the company’s commitment to maintaining fiscal flexibility in its strategic initiatives.